The Bmi-1 proto-oncogene has been upregulated in a large number of cancers such as breast cancer [14], skin cancer [15], lymphoma [12], leukemia [26], and other cancers and is known to be a useful prognostic marker in many cancers. This evidence concerns the gene BMI1 and skin neoplasm.